Follow us on Twitter

Proactive COPDPROactive COPD

Font size: Font SmallFont MediumFont Large

Welcome to the PROactive Website

Latest updates

See PROactive activities and news under the 'News' section.

The Lab validation study

As part of the PROactive project the accuracy of physical activity monitors was tested under well controlled conditions to allow selection of the most suitable activity monitor to measure physical activity in patients with COPD. Read more

PROactive Program

Chronic Obstructive Pulmonary Disease (COPD) is a treatable and preventable lung disease which affects an increasing number of people in Europe. Physical inactivity and its associated symptoms are key features of COPD which contribute to the progression of the disease.

The aim of the 5-year PROactive project (Physical Activity as a Crucial Patient Reported Outcome in COPD) is to develop and validate patient reported outcome (PRO) tools to investigate dimensions of physical activity that are judged as being essential by patients. Currently, the means of measuring the outcomes of physical activity are very generic and do not include the patients\' experiences of how the disease affects their daily lives. The inability of patients with COPD to participate in daily physical activities is an important consequence of COPD, thus representing a daily challenge to patients. Improvement of the ability to participate in physical activity with minimum symptoms is a very important patient-centred target for treatments and other interventions in COPD.

PROactive seeks to address this significant gap, through the development of PRO tools that capture patient daily physical activity in a way that maximally reflect COPD patient experiences in dimensions considered most relevant by the patient. This unique project will be completed in 2014. Here you will find information about this ongoing project, including the latest news and developments, together with all relevant and useful information on COPD. Register now to be kept informed about the latest news.


The PROactive project is funded by the Innovative Medicines Initiative (IMI). More information about the IMI can be found in the ‘About’ section of the website.

Submit Revision
File History